Form 4: STERIS SVP Fraser Reports Stock Vesting, Tax Withholding

STERIS plc's SVP & Chief HRO, Mary Clare Fraser, reported the vesting of restricted shares and the withholding of 207 shares for tax purposes.

Summary

• Mary Clare Fraser, SVP & Chief HRO of STERIS plc, reported a transaction on October 1, 2025, involving the vesting of restricted ordinary shares.
• A total of 692 restricted shares, originally awarded on October 1, 2021, vested on October 1, 2025.
• 207 shares were withheld by the Issuer to cover tax obligations associated with the vesting of these restricted shares.
• The value of the withheld shares was determined by the NYSE closing market price on October 1, 2025.
• Following this transaction, Mary Clare Fraser beneficially owns 12,882 ordinary shares.
• Of the beneficially owned shares, 8,886 remain restricted with future vesting schedules.
• Remaining restricted shares will vest as follows: 2,313 on June 1, 2026; 2,028 on June 2, 2026; 2,040 on June 4, 2027; and 2,505 on June 5, 2028.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to executive compensation (vesting of restricted shares and tax withholding). It does not contain any information that would significantly alter the company's financial outlook or operational status, thus indicating a neutral sentiment.

Industry Context

This filing represents a routine executive compensation event, specifically the vesting of restricted stock units and the associated tax withholding, which is a standard practice across industries for incentivizing and retaining key personnel.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary compensation event for an executive, not a discretionary sale or purchase that would signal a change in sentiment.
• Employees: Reflects standard executive compensation practices, which can be a factor in talent attraction and retention.

Next Steps

• Future vesting of 2,313 restricted ordinary shares on June 1, 2026.
• Future vesting of 2,028 restricted ordinary shares on June 2, 2026.
• Future vesting of 2,040 restricted ordinary shares on June 4, 2027.
• Future vesting of 2,505 restricted ordinary shares on June 5, 2028.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction involving the vesting of restricted stock units and the withholding of shares for tax purposes. Such events are standard components of executive compensation and do not typically indicate a change in the company's fundamental performance or outlook. Therefore, it provides no new information that would warrant a change in an existing investment thesis, leading to a 'hold' recommendation.

Keywords

STERIS, STE, Form 4, Insider Transaction, Stock Vesting, Restricted Shares, Tax Withholding, Executive Compensation